Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Global Health Limited | 8.68m | -6.47m | 8.13m | 49.00 | -- | -- | -- | 0.9367 | -0.1116 | -0.1116 | 0.1495 | -0.0474 | 1.63 | -- | 20.58 | -- | -121.53 | -31.61 | -970.81 | -80.88 | 86.67 | 76.70 | -74.59 | -36.02 | -- | -30.84 | -- | -- | 19.60 | 8.60 | -293.08 | -- | -13.54 | -- |
Control Bionics Ltd | 6.43m | -4.82m | 10.56m | -- | -- | 0.9966 | -- | 1.64 | -0.0471 | -0.0471 | 0.0626 | 0.0532 | 0.6443 | 1.98 | 3.75 | -- | -48.27 | -35.68 | -54.75 | -38.81 | 76.51 | 66.18 | -74.92 | -96.31 | 2.89 | -293.80 | 0.0101 | -- | 25.15 | 45.93 | 7.70 | -- | 99.91 | -- |
Memphasys Ltd | 47.10k | -4.52m | 11.06m | 24.00 | -- | 1.37 | -- | 234.86 | -0.0046 | -0.0046 | 0.00005 | 0.0059 | 0.0033 | 0.2732 | -- | -- | -31.43 | -16.26 | -46.11 | -19.73 | 44.48 | -- | -9,600.13 | -21,518.04 | 0.1368 | -11.78 | 0.456 | -- | -43.39 | -- | -63.43 | -- | 8.14 | -- |
Adherium Ltd | 4.05m | -8.71m | 12.90m | -- | -- | 1.28 | -- | 3.18 | -0.0252 | -0.0252 | 0.0117 | 0.0132 | 0.3584 | 0.9875 | 2.83 | -- | -77.05 | -119.77 | -98.58 | -166.84 | 68.51 | 44.60 | -214.98 | -408.70 | 2.16 | -- | 0.0045 | -- | 50.87 | -3.99 | 1.85 | -- | -39.21 | -- |
Atomo Diagnostics Ltd | 3.11m | -7.37m | 15.98m | -- | -- | 1.17 | -- | 5.14 | -0.0124 | -0.0124 | 0.0052 | 0.0214 | 0.1761 | 0.9634 | 2.18 | -- | -41.73 | -31.79 | -44.36 | -35.88 | 41.97 | 42.26 | -237.01 | -130.74 | 7.06 | -- | 0.0124 | -- | -79.38 | 54.68 | -74.49 | -- | -8.99 | -- |
Cardiex Ltd | 12.90m | -9.41m | 17.36m | 26.00 | -- | 390.48 | -- | 1.35 | -0.0611 | -0.0611 | 0.0748 | 0.0002 | 0.8311 | 0.4655 | 24.75 | -- | -60.59 | -72.35 | -238.37 | -127.53 | 92.90 | 81.46 | -72.90 | -182.60 | 0.847 | -3.38 | 0.9972 | -- | 8.05 | 3.86 | -59.93 | -- | 74.79 | -- |
Singular Health Group Ltd | 2.30m | -3.50m | 18.58m | -- | -- | -- | -- | 8.09 | -0.0292 | -0.0292 | 0.0182 | -0.0004 | 0.8493 | -- | 5.74 | -- | -129.26 | -- | -986.32 | -- | 53.03 | -- | -152.21 | -- | 0.2653 | -- | 1.04 | -- | 143.02 | -- | 9.95 | -- | -- | -- |
ImExHS Ltd | 19.70m | -4.19m | 19.81m | 400.00 | -- | 1.16 | -- | 1.01 | -0.1005 | -0.1005 | 0.472 | 0.3751 | 0.9102 | 127.16 | 3.33 | 49,256.40 | -19.37 | -22.17 | -25.57 | -29.21 | 32.60 | 29.75 | -21.28 | -31.20 | 1.38 | -6.31 | 0.0749 | -- | 14.79 | 26.48 | -37.97 | -- | 5.61 | -- |
Resonance Health Ltd | 5.74m | -1.09m | 23.69m | 18.00 | -- | 2.52 | -- | 4.13 | -0.0025 | -0.0025 | 0.013 | 0.0211 | 0.5077 | -- | 4.93 | -- | -9.61 | -1.60 | -10.51 | -1.71 | -- | -- | -18.93 | -4.00 | -- | -- | 0.0316 | -- | 17.75 | 9.15 | 31.65 | -- | -3.06 | -- |
Data as of Jul 26 2024. Currency figures normalised to Atomo Diagnostics Ltd's reporting currency: Australian Dollar AUD
6.69%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Ellerston Capital Ltd.as of 15 Mar 2023 | 42.74m | 6.69% |
Data from 08 Jul 2024 - 08 Jul 2024Source: FactSet Research Systems Inc.